Experts weigh benefits and risks of new Alzheimer’s disease therapies

FHS
July 27, 2023
3:05 am

New therapies for early Alzheimer’s disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease.

Sino Biological concludes SignalChem acquisition for $48m

Share this article The merger is expected to deliver a wider range of products and services to the life sciences community. Credit: Gorodenkoff/Shutterstock.com. Sino Biological

April 29, 2024

Research shows gut bacteria’s role in mental resilience and reduced anxiety

Researchers characterized brain-gut microbiome (BGM) patterns related to stress resilience.

June 25, 2024

Study suggests link between blood transfusions and brain hemorrhages, but further research needed

Researchers investigated whether spontaneous intracerebral hemorrhages among blood donors after blood donation were linked to the development of spontaneous ICH among transfusion recipients.

September 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.